Disclaimer: "Class II Medical Device", "Not FDA Cleared at this time", "Not currently for sale in the US, nor Internationally as this time"
Cern funding ends tonight!

On behalf of “Team Cern”, thank you for all the support on our current round!
Please, if you haven’t already, finalize your investment in Cern to help bring this much needed therapeutic to market.
Validation!…Start Engine, accepts perhaps 50 companies from over 3000 that apply (About 1.5%). As they mentioned, the acceptance rate is, as they state is “Less then Harvard’s”. Cern’s current raise (Now above $420K) may put us in the top 10% of companies on the platform. Not bad!!!!!!!!!!!!
“The Why”? Because many (especially women and clinicians) understand, we have embarked on a significant, validated “Unmet Need” . One that is focused on the development of an effective non-drug treatment (yet compatible with) for yeast and bacterial vaginosis.
The Cern Device™ is designed for those women, for whom drug based standards of care are neither effective, appropriate, or…desired! Please continue to follow-us as we make tremndous progress.
Thank you again for all the support.
Kind regards, G
More News
30 April 23

Thank you. Let’s stay in touch!
On behalf of “Team Cern”, thank you for all the tremendous support as we bring to market what so many believe...
24 April 23

Cern Webinar: “The Cern Device”
Welcome! You are invited to join a webinar: Drug-Free Treatment for Vaginal Infections: An Introduction to The Cern Device™. After registering,...
08 August 24

OctaneOC Cern Best of Medtech 2024
Cern Corporation has been selected as a finalist for OctaneOC’s prestigious “Best Innovation in Medtech / Device” category ✨ Tech Innovators,...

Cern Corporation was formed to develop and commercialize an effective, non-drug, treatment for fungal and bacteria vaginosis using low-level microbiological light.
Quick Links
© Cern Corporation 2025
Disclaimer: “Class II Medical Device”, “Not FDA Cleared at this time”, “Not currently for sale in the US, nor Internationally as this time”